Health sync

Get the app. Sync your watch, play the Daily Brief.

Install VitaLonga Sync, allow Apple Health or Health Connect, then scan the QR on Tracker with your phone camera. The Daily Brief keeps playing with the screen locked. File import stays as a fallback. Educational numbers only — not medical advice.

Open Tracker Create a member record

Longevity education

Stay curious about aging well — without pretending to be your clinician.

Read today's research headlines, run honest calculators, keep a private record, and assemble an educational supplement protocol. Not a clinic.

Latest news Open calculators Build your protocol

Today's news

Newest story: 5 Nov 2026

News archive →

ScienceDaily · 4 Nov 2026 · Research

Permanent daylight saving time lined up with at least 2 billion more dark morning school trips in a 14-state estimate

ScienceDaily dated its page 4 November 2026. The report covers a Current Biology paper from the University of Washington. Guadalupe Rodríguez Ferrante, Horacio de la Iglesia, and colleagues estimated school commutes before sunrise if daylight saving time stayed in force all year. They used enrollment, start times, and school coordinates in 14 of the 19 states that have already passed supporting measures. Washington state showed nearly 35 million extra dark commutes. Georgia showed about 71 million, the largest of the 14. The nationwide extension, which assumed students leave around 8 a.m., came to at least 2 billion additional dark trips. The authors say that figure is likely low because many children leave earlier. In U.S. crash records, fatal crashes involving school-aged pedestrians were about twice as likely on dark mornings as after sunrise. Mississippi and Alabama, where schools start on average before 8 a.m., moved from about 2 million dark trips under the current clocks to more than 20 million under permanent daylight saving time. The journal paper is dated 29 October 2026. DOI 10.1016/j.cub.2026.10.014. The paper estimates commute lighting and crash timing. Not medical advice.

Read at ScienceDaily →Our summary ♡ Save

sleep
study

ScienceDaily · 4 Nov 2026 · Supplements / medicine

Two Michigan cardiologists list five questions before one-time gene editing is used for high cholesterol and other common diseases

ScienceDaily dated its page 3 November 2026. The feed clock falls on 4 November in Bangkok. The report covers a perspective in JAMA Internal Medicine by Eric D. Smith, M.D., and Venkatesh L. Murthy, M.D., Ph.D., at the University of Michigan. They argue that a one-time genomic treatment is a different decision from a daily medicine that can be changed or stopped. They list five checks: how serious the disease is, whether adjustable treatments already exist, whether the tissue can hold a lasting change, whether the delivery risk fits the disease, and whether safety can be watched for years in very large groups. They note that some existing gene therapies list above $1 million per patient, and that a rare harm can still affect many people if a treatment is given to millions. They mention early work on one-time lowering of LDL cholesterol. This paper is a clinical framework. It does not report a new LDL result. DOI 10.1001/jamainternmed.2026.4690. Not medical advice.

Read at ScienceDaily →Our summary ♡ Save

commentary

ScienceDaily · 4 Nov 2026 · Research

In culture dishes, a palladium complex used carbon monoxide from cancer cells to form a compound the noncancerous cells did not make

ScienceDaily dated its page 3 November 2026. The feed clock falls on 4 November in Bangkok. The report covers a Nature Communications paper from Katsunori Tanaka's group at RIKEN. They enclosed a palladacycle in albumin so glutathione would not shut off the palladium catalyst, then exposed cultured human liver, cervical, breast, and lung cancer cells, plus a noncancerous cell line, for 48 hours. Phenanthridinone showed up in the cancer lines and not in the noncancerous line. A later version of the reaction formed a toxic phenanthridinone derivative inside cultured liver cancer cells, and those cells showed damage. In a laboratory blood test, the toxic compound did not form. The authors attribute that to carbon monoxide already bound to hemoglobin. The paper has no animal experiment and no patient series. DOI 10.1038/s41467-026-77616-8. Not medical advice.

Read at ScienceDaily →Our summary ♡ Save